Brief: Immutep Discontinues Phase III Tacti-004 Study In Non-Small Cell Lung Cancer
08/04/2026 02:24
April 8 (Reuters) - Immutep Ltd IMM.AX: DISCONTINUES PHASE III TACTI-004 STUDY IN NON-SMALL CELL LUNG CANCER ESTIMATES REVIEW PROCESS COULD EXTEND INTO Q3 2026 Further company coverage: IMM.AX ((Reuters.Briefs@thomsonreuters.com;))